Regular Articlec-Jun Does Not Mediate Hepatocyte Apoptosis Following NFκB Inhibition and Partial Hepatectomy☆

Inhibition of the transcription factor nuclear factor kappa B (NFkappaB) induces marked hepatocyte apoptosis and liver dysfunction after partial hepatectomy (PH) in rats. Hepatocyte apoptosis may be due to direct inhibition of NFkappaB-induced hepatocyte survival genes or due to indirect increased signaling through the stress-activated protein kinase pathway (SAPK), resulting in increased c-Jun. c-Jun, an AP-1 transcription factor, induces apoptosis in fibroblasts. Our aim was to determine if hepatocyte apoptosis following inhibition of NFkappaB and partial hepatectomy in rats is due to increased c-Jun. Adult male Sprague-Dawley rats (200 g) were injected intraportally with 6 x 10(9) PFU adenoviral vector containing luciferase (Ad5Luc) or superrepressor IkappaB (Ad5IkappaB) transgene that inhibits NFkappaB translocation into the nucleus. Two-thirds PH was performed 24 h after vector administration, and the remnant liver was harvested 30 min or 24 h after PH. Northern and Western blots were performed to examine the presence of IkappaB and c-Jun. A GST c-Jun kinase assay was used to examine Jun-N-terminal kinase (JNK) activity. AP-1 DNA binding activity was assessed by electrophoretic mobility shift assay. TUNEL assay was performed to assess apoptosis. All rats receiving adenoviral vectors expressed the luciferase or superrepressor IkappaB transgenes. c-Jun mRNA, protein levels, and DNA binding activity were not increased in rats treated with Ad5IkappaB at 30 min after PH compared to rats injected with Ad5Luc. Jun kinase activity increased following partial hepatectomy, but activity was similar in Ad5Luc- and Ad5IkappaB-treated animals. AP-1 DNA binding activity was not altered substantially in rats treated with Ad5IkappaB. The percentage of apoptotic hepatocytes was similar between Ad5Luc- and Ad5IkappaB-injected animals at 0 h, but livers from Ad5IkappaB-treated rats had increased apoptosis at 24 h compared to Ad5Luc rats (24% vs. 4%) after PH. Hepatocyte apoptosis after NFkappaB inhibition and PH is not mediated by increased JNK activity or c-Jun.

[1]  J. Peschon,et al.  Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor , 1998 .

[2]  D. Baltimore,et al.  Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. , 1998, Science.

[3]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[4]  Z. Ao,et al.  IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival , 1998 .

[5]  D. Brenner,et al.  NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.

[6]  Yan-Lin Guo,et al.  Correlation between Sustained c-Jun N-terminal Protein Kinase Activation and Apoptosis Induced by Tumor Necrosis Factor-α in Rat Mesangial Cells* , 1998, The Journal of Biological Chemistry.

[7]  T. Billiar,et al.  Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[8]  A. Ashworth,et al.  A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells , 1997, Current Biology.

[9]  P. Rakic,et al.  Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.

[10]  G. Sonenshein,et al.  Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. , 1997, The American journal of pathology.

[11]  D. Goeddel,et al.  Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Urashima,et al.  Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism , 1997, Oncogene.

[13]  E. Bossy‐Wetzel,et al.  Induction of apoptosis by the transcription factor c‐Jun , 1997, The EMBO journal.

[14]  T. Ishizuka,et al.  Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. , 1997, Biochemical and biophysical research communications.

[15]  G. Natoli,et al.  Activation of SAPK/JNK by TNF Receptor 1 Through a Noncytotoxic TRAF2-Dependent Pathway , 1997, Science.

[16]  J. Ashwell,et al.  Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis , 1997, Molecular and cellular biology.

[17]  E. Furth,et al.  Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.

[18]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[19]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[20]  L. Zon,et al.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis , 1996, Nature.

[21]  R. Taub.  Transcriptional control of liver regeneration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  M. Jordana,et al.  Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. , 1996, The Journal of clinical investigation.

[23]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[24]  B. Viollet,et al.  Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.

[25]  J. Stolarov,et al.  Programmed cell death in the absence of c-Fos and c-Jun. , 1996, Development.

[26]  N. Fausto,et al.  Role of growth factors and cytokines in hepatic regeneration , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[28]  H. Umehara,et al.  Requirement of AP-1 for Ceramide-induced Apoptosis in Human Leukemia HL-60 Cells (*) , 1995, The Journal of Biological Chemistry.

[29]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[30]  D. Brenner,et al.  Sp1 binding activity increases in activated Ito cells , 1995, Hepatology.

[31]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[32]  R. Taub,et al.  Rapid activation of the stat3 transcription complex in liver regeneration , 1995, Hepatology.

[33]  N. Fausto,et al.  Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  D. Brenner,et al.  Activation of Jun kinase is an early event in hepatic regeneration. , 1995, The Journal of clinical investigation.

[35]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[36]  P. Godowski,et al.  In vivo response of hepatocytes to growth factors requires an initial priming stimulus , 1994, Hepatology.

[37]  E. Wagner,et al.  c-Jun is essential for normal mouse development and hepatogenesis , 1993, Nature.

[38]  C. McClain,et al.  Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. , 1992, The American journal of physiology.

[39]  J. Bauer,et al.  Effects of cytokines on the liver , 1991, Hepatology.

[40]  D. Brenner,et al.  Transient induction of C‐jun during hepatic regeneration , 1990, Hepatology.

[41]  G. Michalopoulos.  Liver regeneration: molecular mechanisms of growth control , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  R. Coffey,et al.  Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Hill,et al.  Transforming growth factor β inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver , 1987 .

[44]  T. Nakamura,et al.  Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. , 1985, Biochemical and biophysical research communications.

[45]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[46]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[47]  J. Maizel,et al.  The polypeptides of adenovirus. II. Soluble proteins, cores, top components and the structure of the virion. , 1968, Virology.

[48]  G. Higgins,et al.  Experimental pathology of the liver , 1931 .